COVID-19 NOTIFICATION: To protect your safety in response to the threat of COVID-19, our staff is still available to serve you during our normal office hours. We are offering our clients and potential clients the option to connect with us via telephone, email and video-conferencing. Please call or email us to discuss your options.

Recalls involving medical devices used by patients in West Virginia and other states have increased recently. A new report indicated that recall activity associated with defective medical devices rose by a whopping 38 percent during the second quarter of this year. This makes 2016’s second quarter a tie for the highest quarter since the third quarter of 2014.

According to the recent report about medical devices, even though the recall rate increased during the second quarter this year, it was still below the quarterly average for last year — by 30 percent. In addition, almost all of the recalled items were deemed Class II units. These units are considered relatively high risk and require regulatory controls.

The main reasons for the medical device recalls that have taken place this year are software issues, overall quality and mislabeling issues. These three reasons constitute more than 50 percent of the recalls so far this year. The devices with issues about quality issues mostly involved sterility and specification concerns.

Manufacturers of medical devices are expected to ensure that their devices are safe for the public to use. If defective medical devices end up causing patients harm or even the loss of life, these manufacturers may be held liable for the resulting injuries or deaths. An injured individual in West Virginia may choose to file a product liability claim against the manufacturer of the item causing his or her injury, while the loved ones of a deceased victim might elect to file a wrongful death claim, pursuing the reimbursement of financial damages sustained due to the use of the dangerous product.

Source: beckershospitalreview.com, “Medical device, drug recalls soar in Q2“, Kelly Gooch, Aug. 25, 2016